Doç. Dr. Onur Elbasan

• Diabetes Mellitus, Type 2 5 publications
  Source: OpenAlex / PubMed MeSHView publications
• COVID-19 3 publications
• Thyroid Neoplasms 3 publications

Medical areas of interest stated by the doctor on the institution profile. Source: medicalpark.com.tr.

Experience

• Experience2017 Nisan-2017 Aralık Bursa İznik Devlet Hastanesi İç Hastalıkları Uzmanımedicalpark.com.tr
• Experience2021 Haziran-2025 Ocak Sinop Atatürk Devlet Hastanesi Endokrinoloji ve Metabolizma Hastalıkları Uzmanımedicalpark.com.tr
• Experience2024 Nisan - EYES Research Observership Programme, Department of Internal Medicine, University Hospital Munich Almanyamedicalpark.com.tr

Education

• 20062012 Gazi Üniversitesi Tıp Fakültesimedicalpark.com.tr
• 20122017 Uludağ Üniversitesi Tıp Fakültesi İç Hastalıkları Anabilim Dalı Tıpta Uzmanlıkmedicalpark.com.tr
• 20172021 Marmara Üniversitesi Tıp Fakültesi Endokrinoloji ve Metabolizma Hastalıkları Bilim Dalı Yandal Uzmanlıkmedicalpark.com.tr

• SpecialtyEndocrinology and Metabolic Diseasesmedicalpark.com.trFrom source
• InstitutionMedical Park Maltepemedicalpark.com.trFrom source
• Area of workDiabetes Mellitus, Type 2Extracted from 5 publications · Model version —From source
• Publications54 publicationsORCID, OpenAlexFrom source
• ORCID0000-0001-8580-9471ORCIDFrom source
• Last synchronised4 November 2026 20:34https://www.medicalpark.com.tr/hekimler/onur-elbasanmedicalpark.com.tr

1. Bone health and fracture risk in diabetes: A multicenter study

   Archives of Osteoporosis, 2026

   DOI 10.1007/s11657-026-01667-z PMID 41697544 1 citation (Europe PMC) Open-access full textSource: ORCID

2. Adherence to levothyroxine treatment among patients withhypothyroidism and evaluation of depressive stratus andfactors related with non-adherence

   Endocrine Abstracts, 2025

   DOI 10.1530/endoabs.110.ep1523 Source: OpenAlex

3. Endocrine-disrupting effects of bisphenol-A, thiamethoxam, and fipronil in hormone-naïve transmen compared to cis-women

   Hormones, 2024

   DOI 10.1007/s42000-024-00574-7 PMID 38990460 Open-access full textSource: ORCID

4. Angiotensin-Converting Enzyme (ACE) level, but not ACE gene polymorphism, is associated with prognosis of COVID-19 infection: Implications for diabetes and hypertension

   PLoS ONE, 2023

   DOI 10.1371/journal.pone.0288338 PMID 37432962 6 citations (Europe PMC) Open-access full textSource: OpenAlex

5. The Association of Iodothyronine Deiodinase Gene Polymorphisms and Hashimoto's Thyroiditis: Does Free T3 Play a Role?

   Endocrine Abstracts, 2023

   DOI 10.1530/endoabs.90.p223 Source: OpenAlex

6. Angiotensin-Converting Enzyme (ACE) Level, But Not ACE Gene Polymorphism, Is Associated with Prognosis of COVID-19 Infection: Connection Between Type 2 Diabetes, Hypertension and Renin-Angiontensin-Aldosteron System

   Endocrine Abstracts, 2023

   DOI 10.1530/endoabs.90.p640 Source: OpenAlex

7. Comparison of staging and recurrence predictors in patients with differentiated thyroid cancer between the 7th and 8th editions of the American Joint Committee on Cancer staging systems

   Minerva Endocrinology, 2023

   DOI 10.23736/s2724-6507.22.03791-5 PMID 36756784 Open-access full textSource: ORCID

8. Does total tumour diameter, multifocality, number of tumour foci, or laterality predict lymph node metastasis or recurrence in differentiated thyroid cancer?

   Endokrynologia Polska, 2023

   DOI 10.5603/ep.a2023.0015 PMID 37039491 7 citations (Europe PMC) Open-access full textSource: ORCID

9. Effect of Cross-Sex Hormone Therapy on Hematological Parameters in Transmen: A 1-Year Follow-Up Study

   Endocrinology Research and Practice, 2023

   DOI 10.5152/erp.2023.23256 3 citations (OpenAlex) Open-access full textSource: ORCID

10. Hyperandrogenism-related metabolic changes in drug-naïve transmen compared to cisgender women: a case-controlled study

    Endokrynologia Polska, 2023

    DOI 10.5603/ep.a2023.0052 PMID 37577993 1 citation (Europe PMC) Open-access full textSource: ORCID